Invicta Diagnostic to Launch INR 28-Cr SME IPO on Dec 1 at INR 80-85 Per Share

The offer will close on December 3, while anchor investor bidding is scheduled for November 28.

Mumbai-based Invicta Diagnostic, which operates PC Diagnostics, will open its INR 28.12-crore SME initial public offering (IPO) for public subscription on December 1. The offer will close on December 3, while anchor investor bidding is scheduled for November 28.

The company has set a price band of INR 80-85 per equity share for the fresh issue of 33.08 lakh shares, totaling INR 28.12 crore. Socradamus Capital Pvt Ltd is managing the IPO as the sole book-running lead manager.

According to the company, net proceeds of INR 21.11 crore will be used to purchase medical equipment and establish five new diagnostic centres in Maharashtra. A portion of the funds will also support general corporate purposes.

Invicta Diagnostic offers an extensive range of diagnostic services, including around 60 routine and 487 specialised pathology tests and 96 basic and 130 advanced radiology tests, covering multiple specialties and disciplines.

Financially, the company reported a revenue of INR 16.94 crore and profit after tax (PAT) of INR 4.08 crore for the quarter ended September 2025. For FY25, Invicta Diagnostic posted a revenue of INR 30.09 crore with a PAT of INR 4.92 crore.

Jeena Sikho Lifecare Founder & MD, Acharya Manish Grover, holds a 1.37% stake in the company.

Invicta Diagnostic’s shares are proposed to be listed on the NSE Emerge platform, marking its entry into the public market.

Stay tuned for more such updates on Digital Health News